Christine Rode Andreasen

Publikation

Publikationer pr. år 2021 2021 2023 2024

• 5 Tidsskriftartikel
• 5 Konferenceabstrakt i tidsskrift
• 3 Review
• 2 Konferenceabstrakt til konference
• 1 Mere
  • 1 Ph.d.-afhandling

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2023

  The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease

  Andreasen, C. R., Andersen, A. & Vilsbøll, T., okt. 2023, I: Diabetologia. 66, 10, s. 1846-1858 13 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Incretin 100%
  • Obesity Treatment 100%
  • Non-alcoholic Fatty Liver Disease (NAFLD) 100%
  • Nonalcoholic Fatty Liver 100%
  • A1 Receptor 66%
  17 Citationer (Scopus)
• 2021

  How glucagon-like peptide 1 receptor agonists work

  Andreasen, C. R., Andersen, A., Knop, F. K. & Vilsbøll, T., 17 jul. 2021, I: Endocrine Connections. 10, 7, s. R200-R212

  Publikation: Bidrag til tidsskrift › Review › peer review

  • A1 Receptor 100%
  • Receptor Agonist 100%
  • Glucagon-like 100%
  • Glucagon Like Peptide 1 Receptor Agonist 100%
  • Non Insulin Dependent Diabetes Mellitus 87%

• Understanding the place for GLP-1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection

  Andreasen, C. R., Andersen, A., Knop, F. K. & Vilsbøll, T., sep. 2021, I: Diabetes, Obesity and Metabolism. 23, S3, s. 40-52 13 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Patient Selection 100%
  • Type 2 Diabetes Prevention 100%
  • Agonist Treatment 100%
  • Clinical Patients 100%
  • GLP-1 Receptor Agonist 100%
  20 Citationer (Scopus)